vomiting/diarrhea

BACKGROUND Gastroenteritis attributable to viruses or bacteria is a condition that causes irritation and inflammation of the stomach and intestines (the gastrointestinal tract). Other causes include parasites, food allergens, drug reactions to antibiotics, and ingestion of toxic plants. Vomiting

FIELD OF THE INVENTION The present invention relates to oral pharmaceutical formulations designed to reduce or eliminate adverse effects of drugs typically associated with side effects such as emesis and diarrhea. In particular, the invention is directed to oral pharmaceutical formulations

FIELD OF THE INVENTION The present invention relates to oral pharmaceutical formulations designed to reduce or eliminate adverse effects of drugs typically associated with side effects such as emesis and diarrhea. In particular, the invention is directed to oral pharmaceutical formulations

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to therapeutic treatment of infectious gastroenteritis. 2. Description of the Related Art Normal microflora is important in the protection of the host against diseases of the gastrointestinal (GI) tract (Fuller, R., Gut

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

BACKGROUND OF THE INVENTION Gastrointestinal stimulation, or pacing, was advocated as a possible treatment for gastric motor dysfunction as early as 1963. Experimentation in the late 1960s and early 1970s, began to demonstrate the significance of gastrointestinal myoelectrical activity and its

BACKGROUND OF THE INVENTION 1.Field of the Invention The present invention relates to a new liquid composition, a method for producing this composition and the use of this composition as rehydration drink. 2.Description of the Related Art There are a number of liquid compositions or diluted mixtures

FIELD OF THE INVENTION The present invention relates to the stimulation of health in infants receiving an amino acid based formula. BACKGROUND OF THE INVENTION In a preferred situation, infants are breastfed by the mother. However, often in infants, after an initial period of being breast fed,

BACKGROUND OF THE INVENTION This invention relates to benzimidazolone derivatives. These compounds have selective cannabinoid(CB)2 receptor binding activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives for the

BACKGROUND OF THE INVENTION This invention relates to sulfonyl benzimidazole derivatives. These compounds have selective cannabinoid (CB)2 receptor agonistic activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives

BACKGROUND OF THE INVENTION The present invention relates to pharmaceutical preparations containing substituted aminoalcohols and to the use of substituted aminoalcohols for the production of pharmaceutical preparations and to substituted 2-(aminomethyl)cycloalkan-1-ol compounds and processes for

BACKGROUND There is a constant need in the pharmaceutical industry for improvements on formulations that enable enhanced healing or evaluations of clinical syndromes involving ulceration of epithelium, whether on mucosal surfaces or on epidermal surfaces. The primary improvement of previously

BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to a medical container with an electrolyte stored therein, and more specifically to a medical container which stores therein a body fluid replenisher to be administered through a peripheral vein or a central vein, such as